Mitchell Mcleod Pugh & Williams Inc. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.3% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 8,653 shares of the healthcare conglomerate’s stock after acquiring an additional 23 shares during the period. UnitedHealth Group makes up approximately 1.1% of Mitchell Mcleod Pugh & Williams Inc.’s holdings, making the stock its 20th biggest position. Mitchell Mcleod Pugh & Williams Inc.’s holdings in UnitedHealth Group were worth $5,059,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in UNH. China Universal Asset Management Co. Ltd. increased its holdings in UnitedHealth Group by 20.6% during the first quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after buying an additional 1,857 shares during the last quarter. Quent Capital LLC lifted its position in UnitedHealth Group by 5.5% during the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock valued at $2,076,000 after purchasing an additional 217 shares in the last quarter. Reynders McVeigh Capital Management LLC increased its position in UnitedHealth Group by 5.6% in the first quarter. Reynders McVeigh Capital Management LLC now owns 760 shares of the healthcare conglomerate’s stock worth $376,000 after buying an additional 40 shares in the last quarter. Choate Investment Advisors grew its stake in shares of UnitedHealth Group by 15.6% during the 1st quarter. Choate Investment Advisors now owns 26,644 shares of the healthcare conglomerate’s stock valued at $13,181,000 after acquiring an additional 3,592 shares during the period. Finally, NorthRock Partners LLC lifted its holdings in UnitedHealth Group by 21.0% during the first quarter. NorthRock Partners LLC now owns 8,114 shares of the healthcare conglomerate’s stock valued at $4,014,000 after purchasing an additional 1,408 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Trading Up 1.7 %
Shares of NYSE UNH traded up $10.36 during midday trading on Friday, hitting $615.81. The company’s stock had a trading volume of 3,875,838 shares, compared to its average volume of 3,660,167. The business’s 50 day moving average is $581.93 and its two-hundred day moving average is $545.03. The firm has a market cap of $566.72 billion, a P/E ratio of 40.12, a price-to-earnings-growth ratio of 1.81 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $619.80.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.36%. UnitedHealth Group’s payout ratio is presently 54.72%.
Analyst Ratings Changes
UNH has been the topic of a number of analyst reports. KeyCorp initiated coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 target price on the stock. Royal Bank of Canada cut their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Morgan Stanley dropped their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. UBS Group dropped their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, TD Cowen raised their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.
View Our Latest Research Report on UNH
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Compound Interest and Why It Matters When Investing
- California Resources Stock Could Be a Huge Long-Term Winner
- There Are Different Types of Stock To Invest In
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- How to Read Stock Charts for Beginners
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.